Women and Lung Cancer Research and Preventive Services Act of 2025
Last recorded step: House, Apr 22, 2026.
Nothing scheduled on the calendars we hold.
This bill would require a federal review to expand lung cancer research, screening, and public awareness for women and other populations.
What it does
This bill would require the Department of Health and Human Services to conduct an interagency review focused on accelerating lung cancer research, prevention, and awareness for women and underserved populations. The review would evaluate existing research gaps and identify opportunities for collaborative efforts to improve the screening, diagnosis, and treatment of lung cancer. Additionally, the bill proposes the development of recommendations for a national lung cancer screening strategy and a public education campaign.
Who is affected
The bill primarily affects the Department of Health and Human Services, which is tasked with leading an interagency review of lung cancer research and prevention. The legislation also focuses on women and underserved populations through targeted research, screening strategies, and public education campaigns. Additionally, the bill impacts federal agencies involved in collaborative research regarding the causes, diagnosis, and treatment of lung cancer.
Key provisions
- Interagency review of lung cancer in women and underserved populations. Requires the Department of Health and Human Services to conduct a comprehensive review to accelerate research, prevention, and awareness efforts specifically focused on women and underserved communities.
- Assessment of research status and knowledge gaps. Directs the review to report on the current state of lung cancer research and identify specific areas where more information is needed.
- Identification of collaborative research opportunities. Requires the identification of new ways for agencies to work together to determine the causes of lung cancer and improve methods for prevention, screening, diagnosis, and treatment.
- Recommendations for national screening and education. Mandates the development of recommendations for a national lung cancer screening strategy and a public education campaign.
Fiscal impact
- H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025· As ordered reported by the House Committee on Energy and Commerce on April 29, 2025
Effective dates
Not applicable: Official Summary does not address effective dates
Relationship to existing law
The bill mandates an interagency review of existing research and current knowledge gaps within the Department of Health and Human Services to coordinate and advance federal lung cancer prevention and screening efforts.
Stated purpose
The bill aims to accelerate lung cancer research, prevention, and awareness for women and underserved populations by requiring an interagency review of existing knowledge gaps and research opportunities. It further seeks to establish a national lung cancer screening strategy and a public education campaign to improve the prevention, diagnosis, and treatment of the disease.